Litcius/Paper detail

A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP/PKG/CREB pathway

Jia-yi You, Xinwei Liu, Ying-xia Bao, Zheng-nan Shen, Quan Wang, Gong-yun He, Jing Lü, Jiguo Zhang, Jianwen Chen, Peiqing Liu

2022European Journal of Pharmacology13 citationsDOI

Topics & Concepts

CREBCyclic guanosine monophosphatePhosphodiesteraseNeuroprotectionPharmacologyMedicineApoptosiscGMP-specific phosphodiesterase type 5IschemiaCyclic adenosine monophosphateInternal medicineChemistryReceptorSildenafilBiochemistryNitric oxideEnzymeTranscription factorGenePhosphodiesterase function and regulationHistone Deacetylase Inhibitors ResearchNitric Oxide and Endothelin Effects
A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP/PKG/CREB pathway | Litcius